Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher W Rowe

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Clinical Endocrinology|November 3, 2018
High-dose preoperative cholecalciferol to prevent post-thyroidectomy hypocalcaemia: A randomized, double-blinded placebo-controlled trialChristopher W Rowe, Sam Arthurs, Christine J O'Neill, et al.
Journal of Clinical Medicine|September 28, 2021
Variability in Thyroid Cancer Multidisciplinary Team Meeting Recommendations Is Not Explained by Standard Variables: Outcomes of a Single Centre ReviewMark E Fenton, Sarah A Wade, Bibi N Pirrili, et al.
Endocrinology, Diabetes & Metabolism|February 4, 2023
Current patterns of care in low-risk thyroid cancer-A national cross-sectional survey of Australian thyroid cliniciansWiny Widjaja, Christopher W Rowe, Christopher Oldmeadow, et al.
Endocrine-Related Cancer|March 30, 2017
Targeting the TSH receptor in thyroid cancerChristopher W Rowe, Jonathan W Paul, Craig Gedye, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 9, 2022
Adoption of a pregnancy-specific intravenous insulin protocol (Pregnancy-IVI) at a regional centre has equivalent safety and efficacy outcomes as a tertiary hospitalChristopher W Rowe, Vivian Qiao, Soundarya Ramesh, et al.
Clinical Endocrinology|March 6, 2023
Consensus statement on the management of incidentally discovered FDG avid thyroid nodules in patients being investigated for other cancersJonathan Wadsley, Sabapathy P Balasubramanian, Gitta Madani, et al.
The American Journal of Pathology|June 2, 2020
Clinicopathological Significance of Nerves in Esophageal CancerNathan Griffin, Christopher W Rowe, Fangfang Gao, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 29, 2023
Factors associated with maternal hyperglycaemia and neonatal hypoglycaemia after antenatal betamethasone administration in women with diabetes in pregnancyChristopher W Rowe, Patrick Rosee, Angeline Sathiakumar, et al.
World Journal of Surgery|July 7, 2022
Long-Term Health-Related Quality of Life Outcomes Following Thyroid Surgery for Malignant or Benign Disease: Deficits Persist in Cancer Survivors Beyond Five YearsNicholas D A Blefari, Christopher W Rowe, Elvina Wiadji, et al.
Scientific Reports|February 1, 2020
Innervation of papillary thyroid cancer and its association with extra-thyroidal invasionChristopher W Rowe, Tony Dill, Nathan Griffin, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Clinical Endocrinology|November 3, 2018
High-dose preoperative cholecalciferol to prevent post-thyroidectomy hypocalcaemia: A randomized, double-blinded placebo-controlled trialChristopher W Rowe, Sam Arthurs, Christine J O'Neill, et al.
Journal of Clinical Medicine|September 28, 2021
Variability in Thyroid Cancer Multidisciplinary Team Meeting Recommendations Is Not Explained by Standard Variables: Outcomes of a Single Centre ReviewMark E Fenton, Sarah A Wade, Bibi N Pirrili, et al.
Endocrinology, Diabetes & Metabolism|February 4, 2023
Current patterns of care in low-risk thyroid cancer-A national cross-sectional survey of Australian thyroid cliniciansWiny Widjaja, Christopher W Rowe, Christopher Oldmeadow, et al.
Endocrine-Related Cancer|March 30, 2017
Targeting the TSH receptor in thyroid cancerChristopher W Rowe, Jonathan W Paul, Craig Gedye, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 9, 2022
Adoption of a pregnancy-specific intravenous insulin protocol (Pregnancy-IVI) at a regional centre has equivalent safety and efficacy outcomes as a tertiary hospitalChristopher W Rowe, Vivian Qiao, Soundarya Ramesh, et al.
Clinical Endocrinology|March 6, 2023
Consensus statement on the management of incidentally discovered FDG avid thyroid nodules in patients being investigated for other cancersJonathan Wadsley, Sabapathy P Balasubramanian, Gitta Madani, et al.
The American Journal of Pathology|June 2, 2020
Clinicopathological Significance of Nerves in Esophageal CancerNathan Griffin, Christopher W Rowe, Fangfang Gao, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 29, 2023
Factors associated with maternal hyperglycaemia and neonatal hypoglycaemia after antenatal betamethasone administration in women with diabetes in pregnancyChristopher W Rowe, Patrick Rosee, Angeline Sathiakumar, et al.
World Journal of Surgery|July 7, 2022
Long-Term Health-Related Quality of Life Outcomes Following Thyroid Surgery for Malignant or Benign Disease: Deficits Persist in Cancer Survivors Beyond Five YearsNicholas D A Blefari, Christopher W Rowe, Elvina Wiadji, et al.
Scientific Reports|February 1, 2020
Innervation of papillary thyroid cancer and its association with extra-thyroidal invasionChristopher W Rowe, Tony Dill, Nathan Griffin, et al.
Pageof 3